PLUS THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Plus Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Plus Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.87M, a 10.7% increase year-over-year.
  • Plus Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$12.9M, a 15% increase year-over-year.
  • Plus Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$13.3M, a 34.3% increase from 2022.
  • Plus Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$20.3M, a 51.3% decline from 2021.
  • Plus Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.4M, a 62.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$13.3M +$6.96M +34.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$20.3M -$6.88M -51.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$13.4M -$5.16M -62.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 -$8.24M +$2.65M +24.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$10.9M +$1.75M +13.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-22
2018 -$12.6M +$10.1M +44.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$22.7M -$640K -2.9% Jan 1, 2017 Dec 31, 2017 8-K 2019-09-10
2016 -$22M -$3.3M -17.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 -$18.7M +$18.6M +49.8% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 -$37.4M -$11.2M -42.8% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-11
2013 -$26.2M +$6.1M +18.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
2012 -$32.3M +$172K +0.53% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 -$32.5M -$4.96M -18% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 -$27.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.